K-Ras4A Trafficking and Signaling

K-Ras4A 贩运和信号传递

基本信息

项目摘要

DESCRIPTION (provided by applicant): Ras oncogenes are the most frequently mutated in human cancer. The Ras proteins are small GTPases that control critical cellular pathways for growth, proliferation, and survival, dysregulation of which is implicated extensively in cancer. Of the three Ras genes, mutations in KRAS are the most frequently found in human tumors. There are two splice variants encoded by the KRAS gene: K-Ras4A and K-Ras4B. Much work has been done to characterize Ras biology, but the vast majority of studies have overlooked the K-Ras4A isoform, despite its importance as the original K-Ras viral oncogene. Recent studies have begun to implicate a greater role for K-Ras4A in cancer than previously assumed, but little is still known about the K-Ras4A protein. This proposed work seeks to rectify this by elucidating the cell biology of K- Ras4A with two specific aims. First, we will investigate the targeting signas for K-Ras4A localization and how they are regulated. As membrane association is required for Ras signaling, determining how K-Ras4A is trafficked within the cell is critical in understanding how it exerts its signaling effects. We hypothesize that K-Ras4A is trafficked to the plasma membrane by combined palmitoylation and polybasic interactions, and will test this with live cell imaging studies. Second, we will explore the role that K-Ras4A plays in mediating oncogenesis. We will examine in human cancer cell lines the relative expression levels and dependence on K-Ras4A for survival and tumorigenesis, and study the relative signaling outputs of the two K-Ras isoforms. Our findings from these studies will provide a better understanding of this elusive isoform and contribute to our knowledge of Ras biology. This work will also have significant implications for the design and development of drugs against cancers driven by K-Ras. PUBLIC HEALTH RELEVANCE: K-Ras is the oncogene most frequently mutated in human cancer, and is implicated in more than 30% of human tumors. Understanding the importance and role of the splice isoform K- Ras4A is thus highly significant for the rational design of drugs combating cancers driven by mutations in K-Ras.
描述(申请人提供):RAS癌基因是人类癌症中最常见的突变。RAS蛋白是一种小的GTP酶,它控制着生长、增殖和生存的关键细胞通路,其调节失调广泛地与癌症有关。的 KRAS中的三个RAS基因突变是人类肿瘤中最常见的。KRAS基因编码的剪接变异体有两种:K-Ras4A和K-Ras4B。尽管K-Ras4A亚型作为原始的K-RAS病毒癌基因具有重要意义,但人们已经做了大量的工作来研究RAS的生物学特性,但绝大多数研究都忽略了它。最近的研究已经开始暗示K-Ras4A在癌症中的作用比之前假设的更大,但对K-Ras4A蛋白仍然知之甚少。这项拟议的工作试图通过阐明K-Ras4A的细胞生物学来纠正这一点,并有两个特定的目标。首先,我们将研究K-Ras4A本地化的靶向信号及其调控方式。由于RAS信号需要膜结合,因此确定K-Ras4A是如何在细胞内运输的,对于了解它是如何发挥信号作用至关重要。我们假设K-Ras4A通过棕榈酰化和多碱结合的相互作用被运输到质膜,并将用活细胞成像研究来验证这一点。其次,我们将探讨K-Ras4A在肿瘤发生中的作用。我们将研究K-Ras4A在人类癌细胞系中的相对表达水平和对生存和肿瘤发生的依赖性,并研究两种K-Ras亚型的相对信号输出。我们从这些研究中的发现将提供对这一难以捉摸的异构体的更好的理解,并有助于我们对RAS生物学的了解。这项工作也将对K-RAS驱动的抗癌药物的设计和开发具有重要意义。 公共卫生相关性:K-RAS是人类癌症中最常见的癌基因突变,与超过30%的人类肿瘤有关。因此,了解剪接异构体K-Ras4A的重要性和作用对于药物的合理设计具有重要意义 对抗由K-RAS突变驱动的癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Frederick Deechen Tsai其他文献

Frederick Deechen Tsai的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Frederick Deechen Tsai', 18)}}的其他基金

K-Ras4A Trafficking and Signaling
K-Ras4A 贩运和信号传递
  • 批准号:
    8761389
  • 财政年份:
    2013
  • 资助金额:
    $ 4.72万
  • 项目类别:
K-Ras4A Trafficking and Signaling
K-Ras4A 贩运和信号传递
  • 批准号:
    8460182
  • 财政年份:
    2012
  • 资助金额:
    $ 4.72万
  • 项目类别:
K-Ras4A Trafficking and Signaling
K-Ras4A 贩运和信号传递
  • 批准号:
    8634066
  • 财政年份:
    2012
  • 资助金额:
    $ 4.72万
  • 项目类别:

相似海外基金

Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
  • 批准号:
    BB/Y006380/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.72万
  • 项目类别:
    Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
  • 批准号:
    24K17112
  • 财政年份:
    2024
  • 资助金额:
    $ 4.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
  • 批准号:
    2300890
  • 财政年份:
    2023
  • 资助金额:
    $ 4.72万
  • 项目类别:
    Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
  • 批准号:
    23K06918
  • 财政年份:
    2023
  • 资助金额:
    $ 4.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
  • 批准号:
    23K05758
  • 财政年份:
    2023
  • 资助金额:
    $ 4.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
  • 批准号:
    23K04668
  • 财政年份:
    2023
  • 资助金额:
    $ 4.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
  • 批准号:
    2888395
  • 财政年份:
    2023
  • 资助金额:
    $ 4.72万
  • 项目类别:
    Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 4.72万
  • 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
  • 批准号:
    10728925
  • 财政年份:
    2023
  • 资助金额:
    $ 4.72万
  • 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
  • 批准号:
    10757309
  • 财政年份:
    2023
  • 资助金额:
    $ 4.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了